Joseph G. Ibrahim
Joseph G. Ibrahim
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Bayesian survival analysis
JG Ibrahim, MH Chen, D Sinha, JG Ibrahim, MH Chen
Springer, 2001
Monte Carlo methods in Bayesian computation
MH Chen, QM Shao, JG Ibrahim
Springer Science & Business Media, 2012
Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences
A Zhu, JG Ibrahim, MI Love
Bioinformatics 35 (12), 2084-2092, 2019
High-and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190
JM Kirkwood, JG Ibrahim, VK Sondak, J Richards, LE Flaherty, ...
Journal of clinical oncology 18 (12), 2444-2458, 2000
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma …
JM Kirkwood, JG Ibrahim, JA Sosman, VK Sondak, SS Agarwala, ...
Journal of Clinical Oncology 19 (9), 2370-2380, 2001
Power prior distributions for regression models
JG Ibrahim, MH Chen
Statistical Science, 46-60, 2000
A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma
JM Kirkwood, J Manola, J Ibrahim, V Sondak, MS Ernstoff, U Rao
Clinical Cancer Research 10 (5), 1670-1677, 2004
Missing-data methods for generalized linear models: A comparative review
JG Ibrahim, MH Chen, SR Lipsitz, AH Herring
Journal of the American Statistical Association 100 (469), 332-346, 2005
A new Bayesian model for survival data with a surviving fraction
MH Chen, JG Ibrahim, D Sinha
Journal of the American Statistical Association 94 (447), 909-919, 1999
UGT1A1* 28 genotype and irinotecan-induced neutropenia: dose matters
JM Hoskins, RM Goldberg, P Qu, JG Ibrahim, HL McLeod
Journal of the National Cancer Institute 99 (17), 1290-1295, 2007
Missing data methods in longitudinal studies: a review
JG Ibrahim, G Molenberghs
Test 18 (1), 1-43, 2009
Expression of p16INK4a in peripheral blood T‐cells is a biomarker of human aging
Y Liu, HK Sanoff, H Cho, CE Burd, C Torrice, JG Ibrahim, NE Thomas, ...
Aging cell 8 (4), 439-448, 2009
Basic concepts and methods for joint models of longitudinal and survival data
JG Ibrahim, H Chu, LM Chen
Journal of clinical oncology 28 (16), 2796-2801, 2010
Predictive model selection
PW Laud, JG Ibrahim
Journal of the Royal Statistical Society Series B: Statistical Methodology …, 1995
Use of historical control data for assessing treatment effects in clinical trials
K Viele, S Berry, B Neuenschwander, B Amzal, F Chen, N Enas, B Hobbs, ...
Pharmaceutical statistics 13 (1), 41-54, 2014
Incomplete data in generalized linear models
JG Ibrahim
Journal of the American Statistical Association 85 (411), 765-769, 1990
Estimating cure rates from survival data: an alternative to two-component mixture models
AD Tsodikov, JG Ibrahim, AY Yakovlev
Journal of the American Statistical Association 98 (464), 1063-1078, 2003
Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials
J Manola, M Atkins, J Ibrahim, J Kirkwood
Journal of Clinical Oncology 18 (22), 3782-3793, 2000
Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in …
CI Falkson, J Ibrahim, JM Kirkwood, AS Coates, MB Atkins, RH Blum
Journal of Clinical Oncology 16 (5), 1743-1751, 1998
Missing covariates in generalized linear models when the missing data mechanism is non‐ignorable
JG Ibrahim, SR Lipsitz, MH Chen
Journal of the Royal Statistical Society: Series B (Statistical Methodology …, 1999
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20